SCHEMBL23959771

SCHEMBL23959771

C=C(Nc1cccc2cccnc12)c1ccc(C)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.60
TDP1 Q9NUW8 4/20 0.60
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
KMT2A Q03164 3/20 0.60
ALDH1A1 P00352 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
MEN1 O00255 1/20 0.60
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
POLB P06746 2/20 0.54
HDAC6 Q9UBN7 1/20 0.53
KDR P35968 5/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 2/20 0.52
MITF O75030 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959796 0.86 HDAC6 (0.53) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL16456332 0.83 HDAC6 (0.77) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL23959773 0.83 MAPT (0.60) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL29655132 0.83 HDAC6 (0.77) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL24522583 0.76 KDR (0.51) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL23959786 0.74 CYP1A2 (0.52) MAPTTDP1KMT2ASMN1; SMN2MEN1
SCHEMBL22926774 0.74 HDAC6 (0.61) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL13609772 0.74 TDP1 (0.64) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL1695444 0.73 KDR (0.71) MAPTTDP1NPC1RAB9AKMT2A
SCHEMBL29851236 0.73 KDR (0.71) MAPTTDP1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF HANGZHOU NORMAL UNIVERSITY 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF ABL1, KCNK4, KCNJ4 MAPT 4829/4885TDP1 4114/4885NPC1 4248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.